BrightSpring Health Services, Inc. (BTSG)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Can BrightSpring Health Services, Inc. (BTSG) Keep the Earnings Surprise Streak Alive?
BrightSpring Health Services, Inc. (BTSG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BrightSpring Health Services, Inc. (BTSG) Upgraded to Strong Buy: What Does It Mean for the Stock?
BrightSpring Health Services, Inc. (BTSG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
BrightSpring Health Services, Inc. (BTSG) Q2 2025 Earnings Call Transcript
BrightSpring Health Services, Inc. (NASDAQ:BTSG ) Q2 2025 Earnings Conference Call August 1, 2025 8:30 AM ET Company Participants David Deuchler - Corporate Participant Jennifer A. Phipps - CFO, Chief Accounting Officer & Principal Accounting Office Jon B.
BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates
BrightSpring Health Services, Inc. (BTSG) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.1 per share a year ago.
BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy?
BrightSpring Health Services, Inc. (BTSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is BrightSpring Health Services, Inc. (BTSG) Outperforming Other Medical Stocks This Year?
Here is how BrightSpring Health Services, Inc. (BTSG) and Incyte (INCY) have performed compared to their sector so far this year.
Down 10.4% in 4 Weeks, Here's Why You Should You Buy the Dip in BrightSpring Health Services, Inc. (BTSG)
The heavy selling pressure might have exhausted for BrightSpring Health Services, Inc. (BTSG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
BTSG vs. OPCH: Which Home Infusion Stock is a Better Buy Now?
BTSG surges with 33% infusion growth and stronger EPS gains, making it a more compelling pick than OPCH right now.
BTSG Raises 2025 Financial Outlook: What's Backing It?
BrightSpring boosts 2025 guidance as Pharmacy and Provider segments post strong gains and margin initiatives take hold.
Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds?
BTSG faces margin pressure, but strong first-quarter gains in Pharmacy Solution and Provider Services lift confidence.
3 Medical Services Stocks Capitalizing on the Healthcare AI Boom
CVS, BTSG and WGS are three medical services stocks tapping into AI and tech-driven care to boost diagnostics, cut costs and drive growth in 2025.
BrightSpring's Home Health Arm Soars: What's Powering Growth?
BTSG's Home Health Care Q1 2025 sales surge 21%, fueled by Medicare Advantage gains and high patient satisfaction.
